icad Inc ICAD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
-
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
-
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution
-
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
-
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
-
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
-
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
-
Icad Rises on Google Health Development Deal
Trading Information
- Previous Close Price
- $1.66
- Day Range
- $1.65–1.77
- 52-Week Range
- $1.05–3.97
- Bid/Ask
- $1.68 / $1.81
- Market Cap
- $44.27 Mil
- Volume/Avg
- 193,862 / 159,605
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.23
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 109
- Website
- https://www.icadmed.com
Valuation
Metric
|
ICAD
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.42 |
Price/Sales | 2.23 |
Price/Cash Flow | — |
Financial Strength
Metric
|
ICAD
|
---|---|
Quick Ratio | 2.10 |
Current Ratio | 2.83 |
Interest Coverage | −2,657.80 |
Profitability
Metric
|
ICAD
|
---|---|
Return on Assets (Normalized) | −19.81% |
Return on Equity (Normalized) | −29.37% |
Return on Invested Capital (Normalized) | −28.99% |
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
ABT
| Abbott Laboratories | Zjktgf | $181.2 Bil | |
SYK
| Stryker Corp | Krtp | $110.4 Bil | |
MDT
| Medtronic PLC | Vwgv | $104.8 Bil | |
BSX
| Boston Scientific Corp | Qvwtyv | $80.4 Bil | |
DXCM
| DexCom Inc | Gmvr | $44.7 Bil | |
EW
| Edwards Lifesciences Corp | Xjmyz | $41.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Zcchd | $24.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Ryhrw | $18.6 Bil | |
ALGN
| Align Technology Inc | Ffgxxgj | $16.5 Bil | |
PODD
| Insulet Corp | Fbdsb | $13.3 Bil |